comparemela.com

Latest Breaking News On - ஐரோப்பிய இதயம் இதழ் டிஜிட்டல் ஆரோக்கியம் - Page 1 : comparemela.com

Post-Vax Myocarditis Scare; Left Main Bifurcation PCI; Arrhythmogenic 2016 Election?

New York Times) In response, leaders of the American Heart Association and American Stroke Association assured the public that vaccination s benefits still outweigh the risks. Excess pericardial fat was linked to heart failure, especially among women. ( Journal of the American College of Cardiology) Did the 2016 U.S. presidential election trigger cardiac arrhythmias? ( Journal of the American Heart Association) Young Latinos who are overly anxious about having a heart attack also tend to have mental health problems, University of Houston researchers said. Stroke) The TVT Registry provided reassuring 1-year data on low-risk patients with bicuspid aortic stenosis undergoing transcatheter aortic valve replacement with Sapien 3 and Sapien 3 Ultra devices.

Acarix AB: Positive, long term prognostic data from the Dan-NICAD I study published in European Heart Journal- Digital Health

Acarix AB: Positive, long term prognostic data from the Dan-NICAD I study published in European Heart Journal- Digital Health Positive, long term prognostic data from the Dan-NICAD I study published in European Heart Journal- Digital Health Acarix AB (publ) today announced the publication of the Prognostic study, a study with long term follow up on patients from the Dan-NICAD 1 publication. The long term Prognostic data from the Dan-NICAD 1 trial was first presented at the ESC Congress in September 2019 by Simon Winther, MD, PhD from Aarhus University Hospital, Denmark. The Dan-NICAD 1 trial was initiated in September 2014 to assess non-invasive methods in patients referred to coronary CTA due to symptoms suggestive of obstructive CAD. Clinically relevant prognostic data were assessed with a median follow-up time of 3 years to evaluate the correlation between CAD-score and prognosis in patients treated by current standard of care.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.